MOTS-c and Metabolic Homeostasis in Mice: Landmark Study Summary
A 2015 study characterised MOTS-c as a mitochondrial-encoded peptide and investigated its relationship with metabolic regulation in cells and mice.
A 2015 study characterised MOTS-c as a mitochondrial-encoded peptide and investigated its relationship with metabolic regulation in cells and mice.
Study design
Researchers used cellular metabolic assays and mouse experiments, including diet-related and age-related metabolic models, to examine glucose handling, insulin sensitivity, body-weight-related measures and AMPK-linked pathways.
What the researchers reported
The study reported that MOTS-c influenced folate and purine metabolism, activated AMPK-related signalling and improved several metabolic measurements in the tested mouse models.
What this result does not establish
The findings were preclinical. Improvements in mouse metabolic measurements do not establish treatment of obesity, diabetes or insulin resistance in humans.
This article summarizes one published study about MOTS-c. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards